Review: could Keppra cause Diplopia?


Summary

Diplopia is found among people who take Keppra, especially for people who are female, 50-59 old , have been taking the drug for < 1 month, also take medication Lamictal, and have Epilepsy . We study 34,155 people who have side effects while taking Keppra from FDA and social media. Among them, 229 have Diplopia. Find out below who they are, when they have Diplopia and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Keppra

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Keppra 37,145 users)

Diplopia

Diplopia (double vision) has been reported by people with multiple sclerosis, high blood pressure, depression, pain, rheumatoid arthritis (latest reports from 17,117 Diplopia patients).

On Nov, 20, 2016

34,155 people reported to have side effects when taking Keppra.
Among them, 229 people (0.67%) have Diplopia


Number of reports submitted per year:

Could Keppra cause Diplopia?

Time on Keppra when people have Diplopia *:

  • < 1 month: 40 %
  • 1 - 6 months: 40 %
  • 6 - 12 months: 8 %
  • 1 - 2 years: 4 %
  • 2 - 5 years: 4 %
  • 5 - 10 years: 4 %
  • 10+ years: 0.0 %

Gender of people who have Diplopia when taking Keppra *:

  • female: 77.68 %
  • male: 22.32 %

Age of people who have Diplopia when taking Keppra *:

  • 0-1: 0.0 %
  • 2-9: 0.56 %
  • 10-19: 4.44 %
  • 20-29: 18.33 %
  • 30-39: 21.11 %
  • 40-49: 17.22 %
  • 50-59: 23.89 %
  • 60+: 14.44 %

Severity of Diplopia **:

  • least: 0.0 %
  • moderate: 100 %
  • severe: 0.0 %
  • most severe: 0.0 %

Top co-used drugs for these people *:

  • Lamictal (35 people, 15.28%)
  • Tegretol (31 people, 13.54%)
  • Lyrica (25 people, 10.92%)
  • Carbamazepine (25 people, 10.92%)
  • Vimpat (21 people, 9.17%)

Forecasts by ePatient.care (We will alert you to new symptoms or undetected conditions when you take Keppra, learn more)

Potential co-existing conditions

  • Convulsion (46 people, 20.09%)
  • Pain (16 people, 6.99%)

Potential co-existing symptoms

  • Dizziness (81 people, 35.37%)
  • Fatigue (67 people, 29.26%)
  • Convulsion (58 people, 25.33%)
  • Headache (57 people, 24.89%)
  • Vision Blurred (56 people, 24.45%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Diplopia when taking Keppra?

Browse all side effects of Keppra

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Diplopia

Diplopia

Could your condition cause Diplopia

Diplopia

Related studies

Can you answer these questions?

More questions for: Keppra, Diplopia

You may be interested in these reviews

More reviews for: Keppra, Diplopia


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.